SEC Form 4 · accession 0001209191-16-123347
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rajendra D. Ketkar
Officer — Chief Executive Officer
Period of report
May 23, 2016
Accepted (ET)
May 25, 2016 · 7:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.35 | May 23, 2016 | A | 200,000 | A | — | May 22, 2026 | Common Stock | 200,000 | 200,000 | D |
| Stock Option (right to buy)F1 | $6.00 | May 23, 2016 | A | 225,000 | A | — | May 22, 2026 | Common Stock | 225,000 | 225,000 | D |
| Stock Option (right to buy)F1 | $8.00 | May 23, 2016 | A | 225,000 | A | — | May 22, 2026 | Common Stock | 225,000 | 225,000 | D |
| Stock Option (right to buy)F1 | $12.00 | May 23, 2016 | A | 50,000 | A | — | May 22, 2026 | Common Stock | 50,000 | 50,000 | D |
| Stock Option (right to buy)F1 | $15.00 | May 23, 2016 | A | 50,000 | A | — | May 22, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or May 23, 2017, with the remaining 75% vesting in 36 equal installments beginning May 31, 2017 and ending April 30, 2020.